HK Stock MarketDetailed Quotes
02666 UNI MEDICAL
- 4.820
- +0.050+1.05%
Trading Dec 23 13:07 CST
9.12BMarket Cap4.04P/E (TTM)
4.840High4.770Low1.12MVolume4.770Open4.770Pre Close5.39MTurnover0.06%Turnover Ratio4.09P/E (Static)1.89BShares5.87052wk High0.49P/B9.12BFloat Cap3.36052wk Low0.35Dividend TTM1.89BShs Float7.140Historical High0.350Dividend LFY1.47%Amplitude2.220Historical Low4.810Avg Price500Lot Size7.26%Div YieldTTM7.26%Div Yield LFY
UNI MEDICAL Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 3.46%1.62B | 6.03%2.87B | 3.97%1.56B | 0.43%2.7B | 1.98%1.5B | 13.82%2.69B | 30.79%1.48B | 6.92%2.37B | -5.51%1.13B | 18.98%2.21B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 44.53%-28.4M | -13.44%-84.13M | -38.85%-51.2M | -30.81%-74.16M | -75.99%-36.88M | -30.17%-56.7M | 4.39%-20.95M | 52.27%-43.55M | -110.62%-21.92M | -149.28%-91.25M |
| Investment loss (gain) | 38.72%-4.46M | -99.54%-25.56M | -93.23%-7.28M | -63.35%-12.81M | ---3.77M | ---7.84M | ---- | ---- | ---- | 99.27%-58K |
| Attributable subsidiary (profit) loss | -161.53%-13.64M | 52.61%-6.38M | 10.72%-5.21M | 2.91%-13.46M | 18.14%-5.84M | -22.19%-13.87M | -52.86%-7.13M | -229.85%-11.35M | ---4.67M | ---3.44M |
| Impairment and provisions: | 14.90%109.08M | -36.89%193.83M | -31.00%94.93M | -3.49%307.14M | -19.88%137.59M | 28.61%318.24M | 44.40%171.73M | 5.20%247.45M | 29.89%118.93M | 61.11%235.21M |
| -Impairment of property, plant and equipment (reversal) | ---- | --35K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | --1.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | 14.90%109.08M | -37.46%192.1M | -31.00%94.93M | -3.49%307.14M | -19.88%137.59M | 28.61%318.24M | 44.40%171.73M | 5.20%247.45M | 29.89%118.93M | 61.11%235.21M |
| Revaluation surplus: | -22.96%-53M | -105.93%-263.76M | 59.86%-43.11M | -148.41%-128.08M | -173.25%-107.4M | 173.61%264.59M | --146.61M | 543.14%96.7M | ---- | -195.09%-21.82M |
| -Derivative financial instruments fair value (increase) | -30.31%-53.19M | -1,424.17%-97.38M | 61.07%-40.81M | -102.65%-6.39M | -171.50%-104.83M | 149.61%241.38M | --146.61M | 543.14%96.7M | ---- | -195.09%-21.82M |
| -Other fair value changes | 107.98%183K | -36.72%-166.38M | 10.64%-2.29M | -624.27%-121.69M | ---2.57M | --23.21M | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | 57.96%-1.42M | -272.44%-9.89M | -1,696.21%-3.37M | 21.11%5.74M | -94.16%211K | 220.81%4.74M | 3,869.23%3.61M | 51.23%-3.92M | -24.79%91K | 83.35%-8.04M |
| -Loss (gain) from sale of subsidiary company | ---1.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -199.31%-143K | -94.20%333K | -31.75%144K | 21.11%5.74M | -94.16%211K | 220.81%4.74M | 3,869.23%3.61M | 51.23%-3.92M | -24.79%91K | 83.35%-8.04M |
| -Loss (gain) from selling other assets | ---- | ---10.23M | ---3.51M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 7.04%262.06M | 15.07%508.67M | 24.52%244.83M | 38.37%442.05M | 26.04%196.61M | 18.24%319.46M | 16.46%155.99M | 93.12%270.19M | 157.86%133.94M | 348.17%139.91M |
| -Depreciation | 10.80%237.33M | ---- | 25.31%214.2M | ---- | 26.94%170.94M | ---- | 21.72%134.66M | ---- | 137.91%110.63M | 280.81%114.8M |
| -Amortization of intangible assets | ---- | 12.35%27.45M | ---- | 45.39%24.44M | ---- | 12.32%16.81M | ---- | 74.39%14.96M | ---- | 699.72%8.58M |
| Financial expense | -13.84%1.05B | 15.70%2.35B | 27.35%1.22B | 18.22%2.03B | 17.89%954.66M | -1.91%1.72B | -12.57%809.77M | -6.80%1.75B | 2.81%926.18M | 20.13%1.88B |
| Exchange Loss (gain) | -101.55%-3.04M | -4.98%507.35M | -33.79%196.2M | 1,844.46%533.96M | 609.54%296.36M | -1,136.89%-30.61M | -203.18%-58.16M | -96.63%2.95M | 110.35%56.37M | -1.37%87.64M |
| Special items | -315.40%-1.53M | 332.87%1.18M | -56.72%708K | -108.76%-508K | -43.57%1.64M | 0.00%5.8M | 121.95%2.9M | --5.8M | ---13.21M | ---- |
| Operating profit before the change of operating capital | -8.57%2.93B | 4.20%6.04B | 9.15%3.21B | 11.14%5.8B | 9.63%2.94B | 11.38%5.22B | 15.32%2.68B | 5.67%4.68B | 3.24%2.32B | 23.40%4.43B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -146.58%-8.51M | 184.61%47.57M | 325.55%18.27M | -7.48%-56.22M | 69.17%-8.1M | -122.51%-52.31M | -3.71%-26.28M | 26.11%-23.51M | -454.50%-25.34M | -396.99%-31.82M |
| Accounts receivable (increase)decrease | -636.93%-13.78M | 66.61%-3.99M | 368.43%2.57M | -8,032.65%-11.96M | 676.84%548K | -111.73%-147K | -105.70%-95K | 8.77%1.25M | 95.43%1.67M | 154.29%1.15M |
| Accounts payable increase (decrease) | -296.47%-1.19B | 18.84%1.99B | -37.01%607.81M | 75.71%1.67B | 188.47%964.9M | 713.40%951.08M | 220.71%334.49M | -3.82%-155.05M | -45,525.41%-277.1M | -156.92%-149.34M |
| prepayments (increase)decrease | -110.72%-165.04M | 116.36%34.65M | -269.29%-78.32M | -2.68%-211.86M | 184.80%46.26M | -508.43%-206.33M | -433.17%-54.56M | 27.87%50.52M | 110.98%16.38M | -65.71%39.51M |
| Special items for working capital changes | 53.69%-3.17B | 45.42%-2.47B | -38.39%-6.84B | 32.03%-4.52B | 26.00%-4.94B | -36.44%-6.65B | -494.14%-6.68B | 11.64%-4.87B | 82.47%-1.12B | 39.93%-5.52B |
| Cash from business operations | 47.54%-1.62B | 111.26%5.64B | -208.31%-3.08B | 460.45%2.67B | 73.31%-999.04M | -133.79%-740.42M | -508.78%-3.74B | 74.11%-316.7M | 121.24%915.74M | 76.57%-1.22B |
| Other taxs | -15.21%-385.69M | -3.05%-727.33M | 5.96%-334.77M | 0.55%-705.78M | -8.43%-355.98M | -4.30%-709.69M | -5.09%-328.3M | -8.67%-680.41M | -2.50%-312.4M | -15.04%-626.14M |
| Interest received - operating | -43.65%28.4M | 20.21%82.93M | 46.51%50.4M | 39.25%68.98M | 92.32%34.4M | 95.13%49.54M | 68.22%17.89M | -1.30%25.39M | 2.18%10.63M | -29.73%25.72M |
| Net cash from operations | 41.36%-1.97B | 145.76%4.99B | -154.77%-3.36B | 245.09%2.03B | 67.42%-1.32B | -44.13%-1.4B | -760.25%-4.05B | 46.72%-971.72M | 113.33%613.98M | 68.16%-1.82B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 312,520.00%15.63M | -99.85%5K | -99.85%5K | 2,638.21%3.37M | 2,637.40%3.37M | -49.80%123K | -49.80%123K | -44.44%245K | -44.44%245K | --441K |
| Decrease in deposits (increase) | ---- | 552.17%150M | 552.17%150M | -69.13%23M | -69.13%23M | --74.5M | 6.79%74.5M | ---- | 102.46%69.76M | -103.35%-14.8M |
| Sale of fixed assets | 572.73%1.04M | -75.65%66K | --154K | 86.90%271K | ---- | -72.59%145K | ---- | -96.23%529K | 3,420.00%176K | -80.57%14.02M |
| Purchase of fixed assets | -76.94%-607.53M | -45.15%-896.83M | -129.13%-343.35M | -60.46%-617.87M | ---149.85M | 4.07%-385.07M | ---- | -92.76%-401.39M | -172.27%-186.81M | -1,080.50%-208.24M |
| Sale of subsidiaries | ---43K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | --855K | -167.09%-292.99M | ---- | 819.95%436.73M | 201.99%129.78M | -46.71%47.47M | 2.41%42.97M | -80.50%89.08M | -78.28%41.96M | 3,210.61%456.93M |
| Recovery of cash from investments | 8.42%84.18M | 61.53%275.41M | -39.14%77.64M | 14.04%170.51M | 899.66%127.57M | 53.20%149.51M | -81.09%12.76M | 5,521.67%97.59M | --67.47M | 98.78%-1.8M |
| Cash on investment | 63.09%-92.28M | -1,300.02%-344M | ---250M | 95.15%-24.57M | ---- | -1,854.65%-506.45M | -1,221.29%-132.13M | 92.09%-25.91M | ---10M | ---327.54M |
| Other items in the investment business | 904.27%73.06M | 143.73%49.34M | 103.30%7.28M | -152.08%-112.83M | -414.03%-220.26M | 21.02%-44.76M | -61,112.86%-42.85M | -778.47%-56.67M | 97.97%-70K | -42.63%-6.45M |
| Net cash from investment operations | -46.56%-525.09M | -772.33%-1.06B | -314.69%-358.27M | 81.73%-121.4M | -93.62%-86.4M | -124.10%-664.52M | -158.38%-44.62M | -239.12%-296.53M | 99.37%-17.27M | -124.41%-87.44M |
| Net cash before financing | 32.89%-2.5B | 105.95%3.93B | -164.59%-3.72B | 192.52%1.91B | 65.67%-1.41B | -62.83%-2.07B | -786.84%-4.1B | 33.65%-1.27B | 108.14%596.71M | 64.41%-1.91B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -6.13%26.04B | 40.67%42.98B | 58.86%27.75B | 6.76%30.56B | 15.82%17.47B | 15.33%28.62B | 27.58%15.08B | -9.53%24.82B | -25.96%11.82B | 18.52%27.43B |
| Refund | 3.14%-22.01B | -39.29%-42.07B | -86.71%-22.73B | -28.08%-30.2B | -36.58%-12.17B | -1.85%-23.58B | 11.70%-8.91B | 6.00%-23.15B | -7.54%-10.09B | -51.51%-24.63B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | --1.94B | --2.02B | ---- | ---- | ---- |
| Issuance of bonds | -44.55%497.55M | 242.84%1.65B | --897.36M | -70.79%480M | ---- | --1.64B | --497.61M | ---- | ---- | ---- |
| Interest paid - financing | 18.39%-952.05M | -16.89%-2.32B | -21.16%-1.17B | -17.45%-1.98B | -16.81%-962.84M | 10.65%-1.69B | -2.36%-824.3M | 2.07%-1.89B | 17.45%-805.31M | -40.79%-1.93B |
| Dividends paid - financing | ---- | -1.99%-592M | -2.33%-591.98M | -20.18%-580.46M | -19.78%-578.51M | -6.36%-482.98M | -6.36%-482.98M | -11.52%-454.12M | -11.52%-454.12M | -20.91%-407.21M |
| Absorb investment income | ---- | 389.95%10.78M | --3.32M | --2.2M | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | 14.81%-425.98M | -243.75%-1.65B | ---500.03M | 71.08%-480M | ---- | ---1.66B | ---- | ---- | ---- | ---- |
| Other items of the financing business | 0.81%-1.29B | -162.07%-1.09B | -4,788.62%-1.3B | 184.27%1.76B | 98.30%-26.52M | -232.25%-2.08B | -114.34%-1.56B | 70.59%1.58B | -206.99%-726.73M | 187.23%923.74M |
| Net cash from financing operations | -48.17%1.79B | -140.65%-3.79B | 24.20%3.46B | -165.91%-1.58B | -47.28%2.79B | 7,007.06%2.39B | 561.11%5.28B | -101.15%-34.63M | -116.89%-1.15B | -47.65%3.02B |
| Effect of rate | -99.09%640K | 109.11%2.3M | 272.20%70.63M | -19.42%-25.25M | -346.03%-41.02M | 54.48%-21.14M | -172.88%-9.2M | -145.59%-46.45M | -254.80%-3.37M | 370.96%101.88M |
| Net Cash | -167.98%-704.87M | -57.72%141.33M | -119.08%-263.03M | 2.32%334.25M | 16.35%1.38B | 125.07%326.69M | 315.79%1.18B | -217.32%-1.3B | -1.35%-549.08M | 176.28%1.11B |
| Begining period cash | 5.31%2.85B | 12.89%2.71B | 15.51%2.71B | 17.67%2.4B | 15.00%2.34B | -39.85%2.04B | -39.85%2.04B | 55.78%3.39B | 55.78%3.39B | 24.21%2.17B |
| Cash at the end | -14.65%2.14B | 5.31%2.85B | -31.71%2.51B | 15.51%2.71B | 14.55%3.68B | 15.00%2.34B | 13.37%3.21B | -39.85%2.04B | 73.42%2.83B | 55.78%3.39B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | --4B | -33.23%2.46B | ---- | --3.68B |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | --4B | -33.23%2.46B | ---- | --3.68B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Shinaga Chuwa Certified Public Accountants | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data
